Abstract
This study aims to evaluate cardiac function in cases of intrahepatic cholestasis of pregnancy (ICP) and compare results with those from healthy controls using the fetal left ventricular modified myocardial performance index (LMPI) and E-wave/A-wave peak velocities (E/A ratio). Moreover, the association between LMPI values, total bile acid (TBA) levels, fetal Doppler measurements, and adverse neonatal outcomes was evaluated. A prospective cross-sectional study of 120 pregnant women was conducted, with 60 having ICP and the other 60 serving as controls. Doppler ultrasound and two-dimensional gray-scale fetal echocardiography were used to calculate the LMPI values and E/A ratios, respectively. The association between LMPI values and TBA levels, fetal Doppler measurements, and adverse neonatal outcomes was evaluated. Fetal LMPI values were significantly higher in the ICP group than in the control group (0.54 ± 0.54 vs. 0.44 ± 0.03; p < 0.001), but the E/A ratio was similar in both groups (0.69 ± 0.10 vs. 0.66 ± 0.14; p = 0.203). TBA levels were positively and significantly correlated with LMPI values (r = 0.546, p < 0.01); however, no significant correlation was found between umbilical arterial pulsatility index values and LMPI values (r = 0.071, p > 0.01). LMPI values were not associated with adverse neonatal outcomes in ICP cases. Fetal cardiac function (LMPI) is associated with increased bile acid levels in ICP. However, because it was not associated with adverse neonatal outcomes in ICP cases, the clinical significance of this finding is unclear. Further studies are required to evaluate the implications of increased LMPI.
Similar content being viewed by others
References
Geenes V, Chappell LC, Seed PT et al (2014) Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study. Hepatol Baltim Md 59:1482–1491. https://doi.org/10.1002/hep.26617
Williamson C, Geenes V (2014) Intrahepatic cholestasis of pregnancy. Obstet Gynecol 124:120–133. https://doi.org/10.1097/AOG.0000000000000346
Wikström Shemer E, Marschall HU, Ludvigsson JF et al (2013) Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study. BJOG Int J Obstet Gynaecol 120:717–723. https://doi.org/10.1111/1471-0528.12174
Dixon PH, Williamson C (2016) The pathophysiology of intrahepatic cholestasis of pregnancy. Clin Res Hepatol Gastroenterol 40:141–153. https://doi.org/10.1016/j.clinre.2015.12.008
Brouwers L, Koster MPH, Page-Christiaens GCML et al (2015) Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels. Am J Obstet Gynecol 212(100):e1-7. https://doi.org/10.1016/j.ajog.2014.07.026
Madazli R, Yuksel MA, Oncul M et al (2015) Pregnancy outcomes and prognostic factors in patients with intrahepatic cholestasis of pregnancy. J Obstet Gynaecol J Inst Obstet Gynaecol 35:358–361. https://doi.org/10.3109/01443615.2014.968102
Tei C (1995) New non-invasive index for combined systolic and diastolic ventricular function. J Cardiol 26:135–136
Tei C, Ling LH, Hodge DO et al (1995) New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function–a study in normals and dilated cardiomyopathy. J Cardiol 26:357–366
Severi FM, Rizzo G, Bocchi C et al (2000) Intrauterine growth retardation and fetal cardiac function. Fetal Diagn Ther 15:8–19. https://doi.org/10.1159/000020969
Wong SF, Chan FY, Cincotta RB et al (2003) Cardiac function in fetuses of poorly-controlled pre-gestational diabetic pregnancies–a pilot study. Gynecol Obstet Invest 56:113–116. https://doi.org/10.1159/000073191
Eidem BW, Edwards JM, Cetta F (2001) Quantitative assessment of fetal ventricular function: establishing normal values of the myocardial performance index in the fetus. Echocardiogr Mt Kisco N 18:9–13. https://doi.org/10.1046/j.1540-8175.2001.t01-1-00009.x
Tsutsumi T, Ishii M, Eto G et al (1999) Serial evaluation for myocardial performance in fetuses and neonates using a new Doppler index. Pediatr Int 41:722–727. https://doi.org/10.1046/j.1442-200x.1999.01155.x
Hernandez-Andrade E, Figueroa-Diesel H, Kottman C et al (2007) Gestational-age-adjusted reference values for the modified myocardial performance index for evaluation of fetal left cardiac function. Ultrasound Obstet Gynecol 29:321–325. https://doi.org/10.1002/uog.3947
Bhorat IE, Bagratee JS, Pillay M et al (2015) Determination of the myocardial performance index in deteriorating grades of intrauterine growth restriction and its link to adverse outcomes. Prenat Diagn 35:266–273. https://doi.org/10.1002/pd.4537
Api O, Emeksiz MB, Api M et al (2009) Modified myocardial performance index for evaluation of fetal cardiac function in pre-eclampsia. Ultrasound Obstet Gynecol 33:51–57. https://doi.org/10.1002/uog.6272
Sanhal CY, Daglar HK, Kara O et al (2017) Assessment of fetal myocardial performance index in women with pregestational and gestational diabetes mellitus. J Obstet Gynaecol Res 43:65–72. https://doi.org/10.1111/jog.13174
Alici Davutoglu E, Ozel A, Oztunc F et al (2020) Modified myocardial performance index and its prognostic significance for adverse perinatal outcome in early and late onset fetal growth restriction. J Matern-Fetal Neonatal Med 33:277–282. https://doi.org/10.1080/14767058.2018.1489534
Ozel A, Alici Davutoglu E, Eric Ozdemir M et al (2020) Assessment of fetal left ventricular modified myocardial performance index and its prognostic significance for adverse perinatal outcome in intrahepatic cholestasis of pregnancy. J Matern-Fetal Neonatal Med 33:2000–2005. https://doi.org/10.1080/14767058.2018.1535588
Henry A, Welsh AW (2015) Monitoring intrahepatic cholestasis of pregnancy using the fetal myocardial performance index: a cohort study. Ultrasound Obstet Gynecol 46:571–578. https://doi.org/10.1002/uog.14769
Sanhal CY, Kara O, Yucel A (2017) Can fetal left ventricular modified myocardial performance index predict adverse perinatal outcomes in intrahepatic cholestasis of pregnancy? J Matern-Fetal Neonatal Med 30:911–916. https://doi.org/10.1080/14767058.2016.1190824
Vasavan T, Ferraro E, Ibrahim E et al (2018) Heart and bile acids: clinical consequences of altered bile acid metabolism. Biochim Biophys Acta BBA 1864:1345–1355. https://doi.org/10.1016/j.bbadis.2017.12.039
Herrera CA, Manuck TA, Stoddard GJ et al (2018) Perinatal outcomes associated with intrahepatic cholestasis of pregnancy. J Matern-Fetal Neonatal Med 31:1913–1920. https://doi.org/10.1080/14767058.2017.1332036
Mahajan A, Henry A, Meriki N et al (2015) The (pulsed-wave) Doppler fetal myocardial performance index: technical challenges, clinical applications and future research. Fetal Diagn Ther 38:1–13. https://doi.org/10.1159/000363181
Mielke G, Benda N (2001) Cardiac output and central distribution of blood flow in the human fetus. Circulation 103:1662–1668. https://doi.org/10.1161/01.cir.103.12.1662
Bui YK, Kipps AK, Brook MM et al (2013) Tissue Doppler is more sensitive and reproducible than spectral pulsed-wave Doppler for fetal right ventricle myocardial performance index determination in normal and diabetic pregnancies. J Am Soc Echocardiogr 26:507–514. https://doi.org/10.1016/j.echo.2013.02.006
Ghawi H, Gendi S, Mallula K et al (2013) Fetal left and right ventricle myocardial performance index: defining normal values for the second and third trimesters–single tertiary center experience. Pediatr Cardiol 34:1808–1815. https://doi.org/10.1007/s00246-013-0709-1
de Assunção RA, Liao AW, de Brizot ML et al (2016) Changes in fetal myocardial performance index following intravascular transfusion: preliminary report. J Matern-Fetal Neonatal Med 29:2697–2702. https://doi.org/10.3109/14767058.2015.1101757
Ichizuka K, Matsuoka R, Hasegawa J et al (2005) The Tei index for evaluation of fetal myocardial performance in sick fetuses. Early Hum Dev 81:273–279. https://doi.org/10.1016/j.earlhumdev.2004.07.003
Mullally BA, Hansen WF (2002) Intrahepatic cholestasis of pregnancy: review of the literature. Obstet Gynecol Surv 57:47–52. https://doi.org/10.1097/00006254-200201000-00023
Fan HM, Mitchell AL, Williamson C (2021) ENDOCRINOLOGY IN PREGNANCY: metabolic impact of bile acids in gestation. Eur J Endocrinol 184:R69–R83. https://doi.org/10.1530/EJE-20-1101
Gorelik J, Shevchuk A, de Swiet M et al (2004) Comparison of the arrhythmogenic effects of tauro- and glycoconjugates of cholic acid in an in vitro study of rat cardiomyocytes. BJOG Int J Obstet Gynaecol 111:867–870. https://doi.org/10.1111/j.1471-0528.2004.00166.x
Williamson C, Gorelik J, Eaton BM et al (1979) The bile acid taurocholate impairs rat cardiomyocyte function: a proposed mechanism for intra-uterine fetal death in obstetric cholestasis. Clin Sci Lond Engl 2001(100):363–369
Narin N, Cetin N, Kiliç H et al (1999) Diagnostic value of troponin T in neonates of mild pre-eclamptic mothers. Biol Neonate 75:137–142. https://doi.org/10.1159/000014089
Kawakita T, Parikh LI, Ramsey PS et al (2015) Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol 213(570):e1-8. https://doi.org/10.1016/j.ajog.2015.06.021
Lee RH, Incerpi MH, Miller DA et al (2009) Sudden fetal death in intrahepatic cholestasis of pregnancy. Obstet Gynecol 113:528–531. https://doi.org/10.1097/AOG.0b013e31818db1c9
Acknowledgements
None.
Funding
None declared.
Author information
Authors and Affiliations
Contributions
All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
Corresponding author
Ethics declarations
Competing interests
Authors state no conflict of interest.
Ethical approval
Research involving human subjects complied with all relevant national regulations, institutional policies and is in accordance with the tenets of the Helsinki Declaration (as revised in 2013), and has been approved by the authors. The study protocol was approved by the Local Institutional Ethics Committee (approval number: 2020/ 14-45).
Informed consent
Informed consent was obtained from all individuals included in this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Omeroglu, I., Golbasi, H., Bayraktar, B. et al. Modified myocardial performance index for evaluation of fetal heart function and perinatal outcomes in intrahepatic pregnancy cholestasis. Int J Cardiovasc Imaging 39, 907–914 (2023). https://doi.org/10.1007/s10554-022-02789-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-022-02789-4